Although the anti-apoptotic role and mechanism of galectin-3 in cancer drug resistance have been studied [38], the regulatory pathway and mechanism(s) of chemoresistance-associated proteins modulated by galectin-3 in MDR cancer cells have not been fully elucidated. Here, LGALS3 is linked to cancer.